SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop new therapeutic approach for geographic atrophy – advanced ...
Groupe OKWIND Announces Solid Commercial and Financial Performance for 2023
Groupe OKWIND (FR0013439627 – ALOKW), which is specialized in the design, manufacture and sale of smart energy generation and management systems dedicated to self-consumption, today announces its ...
Mena FN17d
CARBIOS Announces Fiscal-Year 2023 Financial Results And Confirms 2024 Calendar For Industrial And Commercial Roll-Out
For FY 2023: On R&D, the Group spent €18,958 thousand. The slight decrease in R&D expenses is mainly due to the launch of the OPTI-ZYME project financed by ADEME, under which the Group's academic ...
LANDMARK 2023 FINANCIAL YEAR FOR AIRWELL: RECORD 2023 REVENUE: EUR 65.0M - EBITDA MARGIN: 4.8%, IN LINE WITH THE TARGET - SOUND FINANCIAL STRUCTURE
IN LINE WITH THE TARGET SOUND FINANCIAL STRUCT U RE The Airwell Group (Euronext Growth, ALAIR), creator of smart energy ecosystems, reports its full-year ...
Oncodesign Precision Medicine (OPM) obtains ¬5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101
The government has allocated ¬5.6 M of funding to the DEMOCRITE program for a total project cost of ¬12.5 M. The funding will be provided as a grant (¬1.7 M) and repayable advances (¬3.9 M) for a ...